A detailed history of Advisor Group Holdings, Inc. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 167 shares of KROS stock, worth $2,859. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167
Previous 233 28.33%
Holding current value
$2,859
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$41.68 - $58.07 $2,750 - $3,832
-66 Reduced 28.33%
167 $9,000
Q2 2024

Aug 13, 2024

SELL
$44.58 - $66.89 $2,942 - $4,414
-66 Reduced 22.07%
233 $10,000
Q1 2024

May 10, 2024

SELL
$41.26 - $70.48 $17,370 - $29,672
-421 Reduced 58.47%
299 $19,000
Q4 2023

Feb 12, 2024

SELL
$27.12 - $41.05 $4,447 - $6,732
-164 Reduced 18.55%
720 $28,000
Q2 2023

Aug 10, 2023

BUY
$37.26 - $51.01 $32,937 - $45,092
884 New
884 $35,000

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $441M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.